Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its Chairman and CEO, Dr. Amit Kumar, ...

Patients with metastatic cancer had better quality of life, clinical outcomes, and sense of well-being when they regularly ...

Almost one in five reported paying privately for some part of their diagnosis or treatment to save their lives. Margaret and ...

Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...

A groundbreaking study has uncovered how specific genetic mutations influence cancer treatment outcomes -- insights that could help doctors tailor treatments more effectively. The largest study of its ...

A study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence ...

The research uncovers key genetic mutations that affect cancer treatment responses and develops a predictive tool for ...

As the ovaries are close to the bladder, ovarian cancer can cause frequent urination, leaking, needing to pee with urgency, ...

The company is also focusing on establishing large-scale manufacturing capabilities with Northex ... have a positive start of treating ovarian cancer patients with VDNCELL and that we can observe ...

Amid 50 years of gut-busting comedy, the Lorne Michaels iconic sketch show has replaced humor with heartache during tear-inducing tributes to 9/11, mass shootings, wars and more, offering somber ...